The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study
about
Does tight control of systemic factors help in the management of diabetic retinopathy?Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic RetinopathyDiabetic retinopathy and systemic factorsDiabetic macular oedema: clinical risk factors and emerging genetic influences.Fenofibrate and Diabetic Retinopathy.New Therapeutic Approaches in Diabetic Retinopathy.Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control aloneDiabetic Retinopathy: A Position Statement by the American Diabetes Association.Lipotoxicity augments glucotoxicity-induced mitochondrial damage in the development of diabetic retinopathyHigh Prevalence of Diabetic Retinopathy in Diabetic Patients Concomitant with Metabolic Syndrome.Future opportunities in diabetic retinopathy research.Diabetic macular oedema: pathophysiology, management challenges and treatment resistance.Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression.Evidence-Based Treatment of Diabetic Retinopathy.Evidence-Based Treatment of Diabetic Macular Edema.ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.Diabetic retinopathy care in India: An endocrinology perspective.Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On StudyPeripheral Blood Mitochondrial DNA Damage as a Potential Noninvasive Biomarker of Diabetic RetinopathyAssociation of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathySafety considerations with fenofibrate/simvastatin combination.Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice.Ascorbic acid repletion: A possible therapy for diabetic macular edema?Effect of micronized fenofibrate on microvascular complications of type 2 diabetes: a systematic review.Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy.Hypertensive eye disease: a review.Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2.Influence of serum lipids on the incidence and progression of diabetic retinopathy and macular oedema: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular genetics Study-II.Association of serum lipid levels with retinal hard exudate area in African Americans with type 2 diabetes.Predictors of Development and Progression of Retinopathy in Patients with Type 2 Diabetes: Importance of Blood Pressure ParametersHyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models.Semi-automated quantification of hard exudates in colour fundus photographs diagnosed with diabetic retinopathy.Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF AgentsThe Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.Astragaloside IV protects rat retinal capillary endothelial cells against high glucose-induced oxidative injury.Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy.Effects of lipid-lowering agents on diabetic retinopathy: a Meta-analysis and systematic review.The effect of fenofibrate on early retinal nerve fiber layer loss in type 2 diabetic patients: a case-control study.
P2860
Q28074223-45250C73-AE3D-44D3-BECE-FE4FA5C0C556Q28078199-B627AC80-2113-47A5-BC26-E1C60433208EQ28082046-D4B24B21-3445-489D-84D4-C4D6E6FB8DE5Q30234323-F9F11E43-96F2-499F-B074-94639A893319Q30248492-666FB52E-501B-4FA3-9F80-1AAAF2629300Q33583037-A8EE3D30-9FC5-41AF-8C38-A1AFF96E452CQ33853527-9A53E191-D581-4D1D-B884-DCEE232089D0Q34551730-3D58CD6A-4694-477D-8FFD-11F3BC12BE34Q35608796-4D9F7F1E-BF91-42D3-886A-03A57D06AC7DQ35888609-024655A7-02D8-42E4-A46C-36B746894596Q35935835-4D243056-E827-4C72-B9CE-ED444C4E78FEQ36018006-245ED5CC-F87D-4B0E-B942-A6E0BE80A062Q36082885-EE31D797-7F29-4A8A-BC2C-7CD1FEAF4E7FQ36114211-E5B9DB11-0BB0-4332-B84E-02F8C3313572Q36152543-FF63FD7C-7BF8-4469-9B03-AB58E44C2BD6Q36242390-74926F5E-2481-4EF2-9F67-08890F84651BQ36374238-7F6C1E39-1EAC-45F5-BADA-F3A1821FE23EQ36842792-82A9A513-D469-4198-A99B-FFF81AB59C30Q37025572-55EA6818-362F-4911-8278-3CC7CD4FCF7BQ37179655-89CF3D64-8B06-4B48-991C-C349A9E78BA2Q37569809-1D21DCCD-97FE-4465-AF01-A66013B80C19Q38541832-2A045FF6-F8D9-40B8-B3B6-D36A22F7A1D7Q38719213-14730C78-C993-4047-AEAF-202C4D0B06B5Q38742663-0C3C19B5-3253-407C-A669-5E119FF5799EQ38856838-839949DE-A9D8-480A-BCCB-C84967005997Q38873909-D6BADAB3-3D9A-44E0-B8E1-599155CDF7C9Q39042956-8A0EDE2F-55F5-48F3-8FBE-9FD720B3FFD2Q39052777-B04FBC8C-5E66-427C-B1CB-2E4B1EA67EE0Q40198580-19611D72-6D26-4CDF-8064-411EFA417529Q40579996-CF8445F2-7CFE-4036-9FB1-D15D5E8599B2Q40961352-028FD2B8-5F0C-40CB-9F27-A5EABAF43AC0Q41653304-2AB5695E-42F4-49E0-B801-E9E1E19E0174Q41695768-902A4CBA-B561-4508-AFD3-A328711E472AQ41998002-46D54187-32D1-4011-9E50-79363190B46AQ42292833-CD2086A5-F601-4BFF-8438-F8B6D0745CA7Q47095933-7153885B-EF86-4A1A-82BF-DA2D594654E2Q47443616-A6B1F230-AC54-4FA3-B0AF-F6C53829512CQ49169179-83C13DAE-EF12-4C0D-8534-01849854B997Q50299048-11E1EC58-08F9-43FC-849D-969EDC5CE939Q52579979-9C54DD5F-9A9E-4C4D-91FD-028A61EED887
P2860
The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The effects of medical managem ...... in Diabetes (ACCORD) Eye Study
@ast
The effects of medical managem ...... in Diabetes (ACCORD) Eye Study
@en
The effects of medical managem ...... ardiovascular Risk in Diabetes
@nl
type
label
The effects of medical managem ...... in Diabetes (ACCORD) Eye Study
@ast
The effects of medical managem ...... in Diabetes (ACCORD) Eye Study
@en
The effects of medical managem ...... ardiovascular Risk in Diabetes
@nl
prefLabel
The effects of medical managem ...... in Diabetes (ACCORD) Eye Study
@ast
The effects of medical managem ...... in Diabetes (ACCORD) Eye Study
@en
The effects of medical managem ...... ardiovascular Risk in Diabetes
@nl
P2093
P2860
P1433
P1476
The effects of medical managem ...... in Diabetes (ACCORD) Eye Study
@en
P2093
Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group
Craig Greven
David C Goff
Faramarz Ismail-Beigi
James F Lovato
Lawrence A Leiter
Letitia H Perdue
Matthew D Davis
Ronald P Danis
Saul Genuth
P2860
P304
P356
10.1016/J.OPHTHA.2014.07.019
P50
P577
2014-08-29T00:00:00Z